Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. - Wikidata - wikimedia - TriplyDB

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

http://www.wikidata.org/entity/Q37562665

about

Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury Treating Negative Symptoms in Schizophrenia: an Update Immune interventions in stroke Bridge between neuroimmunity and traumatic brain injury Neuroprotection for stroke: current status and future perspectives Antioxidants: The new frontier for translational research in cerebroprotection Treatment of fever after stroke: conflicting evidence Cocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective The immunology of stroke: from mechanisms to translation Minocycline protection of neomycin induced hearing loss in gerbils.Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair Targeting microglial activation in stroke therapy: pharmacological tools and gender effects.Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.Enrollment of research subjects through telemedicine networks in a multicenter acute intracerebral hemorrhage clinical trial: design and methods Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells.Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.Minocycline development for acute ischemic stroke Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke Breaking out from the neuroprotective logjam: combined treatment with remote ischemic conditioning and minocycline in the prehospital setting Antioxidant strategies in neurocritical care Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke.Noninvasive molecular imaging of neuroinflammation Clinical neuroprotective drugs for treatment and prevention of stroke.The neurovascular unit and combination treatment strategies for stroke Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.Minocycline prevents IL-6 increase after acute ischemic stroke Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke Influence of inflammation on poststroke plasticity Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline.Anti-inflammatory effect of cholera toxin B subunit in experimental stroke.Systems Biology of Immunomodulation for Post-Stroke Neuroplasticity: Multimodal Implications of Pharmacotherapy and Neurorehabilitation

P2860

Q21285148-E6C493EB-59E2-4283-B52B-8FC30E66CDDA Q26744805-AC8A0BAA-D470-461E-A9D6-E2F82A4F07CA Q26797993-185E0B8B-A46B-4B0F-BEB8-0D6586313071 Q26827612-CD2DAC20-1259-45C8-9F90-3D2205283C16 Q26853031-088128BA-FEDA-4904-A012-D5CD14A8FB78 Q26863595-76D22E50-432E-424D-8979-1E600C331EFC Q27016022-03DEC4E4-473D-4B61-9A95-2E46FE277A8A Q28077232-ECABB5DE-5AB3-4E1D-89F8-6D298B794A5A Q28393202-04E06E95-9581-4A99-9C4A-6FBDA16F3AB9 Q29620066-03410C1B-8DDD-4D7A-8D56-C3A35D255718 Q30412597-87BF1A2C-30E6-4EB3-9DD3-7739A0F67F92 Q33456516-E69F9E48-B49D-4AF0-A094-8F6CBCDAE8D4 Q33583258-F76056F2-482A-491E-BF5B-038A319B50CE Q33824991-A34DCD0A-55E1-4734-8150-D60417BAE6CC Q33863549-0B4D1349-3D46-42F7-9502-BA8C2783E8AA Q33892142-CAE87E31-3827-4E31-96C8-805B54280C8C Q33925611-B662B9A8-71CA-4D9F-9CB9-2A995B89E020 Q34241228-887D9C69-82BE-4BA3-B734-D90F9EF79683 Q34300317-D440A6C9-2EC4-4A4A-B671-60C83460927F Q34674246-4F9C77E7-4B68-4617-A2EA-6F3BDB82461A Q34719602-A6463AC2-0439-4082-A9CF-9F5EBC877600 Q35120831-79F496B0-875F-42C6-A8CA-AE8FD0C42657 Q35202559-8D0B42C0-A8C3-4EC1-85A3-BBADB288E1BE Q35234799-83C1229E-1C29-4851-8797-75495E03C7EE Q35584528-152E4D52-1E7B-4FAF-BF1F-D79404CC2BD6 Q35729668-614CB050-D011-4CB3-A8B1-73030B17094A Q35779826-CC229EB4-6D1F-4A68-9A95-1DDF360D56BF Q36079268-74F2C418-EC9C-4121-BD9C-5B07A740F3D3 Q36097037-071F4DA6-9F11-4DE7-8398-E99F4FD720AA Q36124038-F19EF772-C1C8-4DD1-B06E-7B6ED4E69D31 Q36256704-C43950C0-1C50-45F3-9D5B-08E7660A426C Q36345955-8E999FEB-1BB6-4FAE-B37B-DF658CDD88E5 Q36614594-6956DBE4-5825-4503-ACAA-770BD1F6426A Q36679022-D6197529-B46B-4B44-813F-BEE0A2BBDF0B Q36700111-93B20997-CACA-4727-BFC4-826BDD82E19A Q36736442-3B49D614-E85B-4806-BE78-C64B042A0126 Q36783536-985DA114-3C36-4680-A92C-5531CF08E5E4 Q36831052-C91DA9DE-BBCF-468C-ABDB-F63D4FDE6FA8 Q37001778-DCC6E5CB-B543-44D5-A960-371132955CC0 Q37043237-E9BEEA54-4968-4081-B78B-3706347B3E4E

P2860

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

http://www.wikidata.org/entity/Q37562665

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

@en

Minocycline to improve neurologic outcome in stroke

@nl

type

label

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

@en

Minocycline to improve neurologic outcome in stroke

@nl

prefLabel

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

@en

Minocycline to improve neurologic outcome in stroke

@nl

P1433

Q37562665-AA87B1E9-DABF-4246-BBBC-EE0F5478B5A4

P1476

Q37562665-1CF4AC8E-C243-4314-A0FC-4149D7EE4C5E

P2093

Q37562665-160FC483-2112-4F82-960B-1278F1DAA071

Q37562665-170E1313-AA90-40E0-ADCE-484088C9DB23

Q37562665-1C90DA84-E149-48CB-B12F-2F6EAA0F52A8

Q37562665-252EF335-3AAA-4CAA-9D1B-88B8964EE26E

Q37562665-2E76505A-9D01-4FEB-991D-7B4F888E5D1F

Q37562665-C6CC2A3C-11B0-4A7B-8736-A57C72ADE671

Q37562665-E0B34E7E-431B-4820-B147-7A5D7D8C58F7

Q37562665-E0D80BC2-2AE1-4A0A-84C7-59644B8AC7A3

Q37562665-E2E38651-FE95-42C6-8ADB-A5715AC0EADF

Q37562665-EEB5B4E8-5BEE-444D-9EBA-98DA2C326293

P2860

Q37562665-05AFE20C-7448-480C-9747-961F465229F3

Q37562665-0C0BFB24-08D1-4F04-8F22-CFB607A8B39A

Q37562665-4DB2500E-0E13-4F77-83D5-506C49EE620D

Q37562665-53254625-93AD-4A17-B3FB-FE28AE714B23

Q37562665-537073C3-69A4-4346-AE5E-A9E466718BDC

Q37562665-5A5D2A64-E049-4E2A-88C1-F1500BFFC242

Q37562665-67B0463C-3A74-4849-9BA4-F0509E83B987

Q37562665-698D6553-B2CA-433F-B464-ABE6E5F18916

Q37562665-6C87EDC7-2086-4983-867B-15C9377288BA

Q37562665-88AD7E8E-C837-4F59-B563-99375CDC2217

P304

Q37562665-6384E874-B521-4C08-9DCA-C13FAD7B5EED

P31

Q37562665-9D3672B4-2DCB-4224-ABF6-31A7D14BF556

P356

Q37562665-91A2ADF5-9383-4BA5-8B1F-06825AEAD5D3

P407

Q37562665-8BE310DD-6812-4D53-8E2A-1120F417289F

P433

Q37562665-5889AFAE-E699-4433-A1D6-65808728F153

P478

Q37562665-B2B00821-801E-494E-A292-E8C363A89DD5

P577

Q37562665-227D4C53-ADD4-454D-9B3A-7600EA3AEA64

P698

Q37562665-5F28E957-D832-4A9A-807F-92CA0CB3A52B

P932

Q37562665-3E8B5878-5470-4EDF-B3D6-47EF9054A1CB

P356

STROKEAHA.110.582601

P1433

P1476

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

@en

P2093

Adviye Ergul

http://www.w3.org/2001/XMLSchema#string

Christiana E Hall

http://www.w3.org/2001/XMLSchema#string

David C Hess

http://www.w3.org/2001/XMLSchema#string

David J Edwards

http://www.w3.org/2001/XMLSchema#string

Fenwick T Nichols

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Switzer

http://www.w3.org/2001/XMLSchema#string

Jennifer L Waller

http://www.w3.org/2001/XMLSchema#string

L Creed Pettigrew

http://www.w3.org/2001/XMLSchema#string

Susan C Fagan

http://www.w3.org/2001/XMLSchema#string

Wayne M Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats

Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

Pharmacokinetics of minocycline in renal failure.

P304

2283-2287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.110.582601

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20705929

http://www.w3.org/2001/XMLSchema#string

P932

3916214

http://www.w3.org/2001/XMLSchema#string